Innovent Releases Results of a Phase 1 Clinical Study of IBI362, a Dual Glucagon-like Peptide-1 and Glucagon Receptor Agonist in Chinese Patients with Type 2 Diabetes at the International Diabetes Federation Congress 2021 ...Middle East

Hence then, the article about innovent releases results of a phase 1 clinical study of ibi362 a dual glucagon like peptide 1 and glucagon receptor agonist in chinese patients with type 2 diabetes at the international diabetes federation congress 2021 was published today ( Tuesday 07/12/2021 - 03:10 AM ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( Innovent Releases Results of a Phase 1 Clinical Study of IBI362, a Dual Glucagon-like Peptide-1 and Glucagon Receptor Agonist in Chinese Patients with Type 2 Diabetes at the International Diabetes Federation Congress 2021 )

Also on site :

• Can Pakistan-administered Kashmir’s election overcome a violent summer?
• After SpaceX’s $2 trillion debut, investors are eyeing Anthropic and OpenAI. Market experts share how to play the next trillion-dollar IPO
• Ukraine-Russia war latest: Zelensky sacks armed forces chief in biggest military shakeup since Putin’s invasion